Aquestive Therapeutics, Inc.
Anaphylm
Type I allergic reactions, including anaphylaxis
Resolved
158days ago
FDA decision · Jan 30, 2026
What's at stake
An FDA complete response letter on Anaphylm for Type I allergic reactions, including anaphylaxis is in focus around Jan 30, 2026.
Primary source
· SEC 8-K
verified 16h ago
“Anaphlym CRL issued on January 30, 2026”